Clinical trials: Heat Sensitivity

Capsaicin Evoked Pain, Heat Sensitivity

Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)

• Completed
• Age: 20 to 45 years
• Phase 1
• Pill or oral medicine

A double-blind, randomized, single-centre, placebo-controlled, crossover study to investigate the effects of a single oral dose of AZD1386 on intradermal capsaicin evoked pain symptoms and heat sensitivity in healthy volunteers

Trial name

NCT00692146

Testing

AZD1386

Volunteers

36 people, healthy volunteers welcome

Sponsor

AstraZeneca